Cargando…
Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy
CD4(+) regulatory T cells (Tregs) are essential for normal immune surveillance, and their dysfunction can lead to the development of autoimmune diseases, such as type-1 diabetes (T1D). T1D is a T cell-mediated autoimmune disease characterized by islet β cell destruction, hypoinsulinemia, and severel...
Autor principal: | Song, Jianxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086452/ https://www.ncbi.nlm.nih.gov/pubmed/27799873 http://dx.doi.org/10.4110/in.2016.16.5.281 |
Ejemplares similares
-
Regulatory T-cell vaccination independent of auto-antigen
por: Pascual, David W, et al.
Publicado: (2014) -
Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
por: Poojary, Rayansh, et al.
Publicado: (2023) -
Clostridium butyricum in combination with specific immunotherapy converts antigen-specific B cells to regulatory B cells in asthmatic patients
por: Liao, Hong-Ying, et al.
Publicado: (2016) -
Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
por: Creusot, Rémi J., et al.
Publicado: (2018) -
Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes
por: Thomas, Ranjeny, et al.
Publicado: (2021)